Skip to main content
. Author manuscript; available in PMC: 2019 Nov 1.
Published in final edited form as: J Cardiol. 2019 Jul 12;74(5):397–402. doi: 10.1016/j.jjcc.2019.06.004

Figure 1.

Figure 1

In heart failure with preserved ejection fraction there is microvascular inflammation that activates the endothelial to begin a cascade of adverse effects that leads to left ventricular dysfunction.

ATP, adenosine triphosphate; cGMP, cyclic guanosine monophosphate; LV, left ventricular.